Kabuki syndrome is a rare genetic condition present from birth that affects multiple body systems, causing distinctive facial features, intellectual disability, growth problems, and skeletal differences. It occurs in roughly 1 in 32,000 births in Japan and at least 1 in 86,000 births in Australia and New Zealand, though it’s now recognized worldwide. The name comes from the resemblance of affected individuals’ facial features to the stylized makeup worn by actors in traditional Japanese Kabuki theater.
What Causes Kabuki Syndrome
Kabuki syndrome results from a mutation in one of two genes. The first, KMT2D on chromosome 12, accounts for the majority of cases, detected in roughly 34 to 76% of clinically diagnosed patients depending on the study. The second, KDM6A on chromosome X, explains about 10% of cases. Both genes produce proteins that help regulate how other genes are switched on and off during development, a process that influences how tissues and organs form before birth.
Most cases arise from a new, spontaneous mutation rather than being inherited from a parent. Once a person carries the mutation, however, it can be passed to future children. KMT2D mutations follow an autosomal dominant pattern, meaning a single copy of the altered gene is enough to cause the condition. KDM6A mutations are X-linked, which can affect how the condition presents differently in males and females. In a notable portion of clinically diagnosed patients, neither gene mutation is found, suggesting other genetic mechanisms may be involved.
Recognizing the Facial Features
The most recognizable hallmark is a distinctive facial appearance that becomes more evident over time. Key features include long eye openings with the outer portion of the lower eyelid turning slightly outward, arched eyebrows that thin out or show notching toward the outer edges, a short nasal bridge with a depressed tip, and large or prominent ears. Cleft lip or cleft palate can also occur. These features are sometimes subtle in infancy and become more apparent as a child grows.
The Five Cardinal Features
Clinicians look for five core characteristics when considering a Kabuki syndrome diagnosis:
- Distinctive facial features as described above
- Skeletal abnormalities such as curved spine, shortened fingers, or joint hypermobility
- Dermatoglyphic abnormalities, most notably persistent fetal fingertip pads, the soft, rounded cushions on the fingertips that normally flatten during fetal development
- Mild to moderate intellectual disability
- Postnatal growth deficiency, meaning children are typically a normal size at birth but fall behind in height and weight afterward
Not every person with Kabuki syndrome has all five features. The condition varies widely in severity, even among individuals with the same gene mutation.
How Diagnosis Works
An international consensus published in 2019 established formal diagnostic criteria. A definitive diagnosis requires a history of low muscle tone in infancy (hypotonia), developmental delay or intellectual disability, and at least one of two major criteria: either a confirmed disease-causing mutation in KMT2D or KDM6A, or the typical facial features. The facial criteria require long eye openings with lower eyelid eversion plus two or more additional features such as arched eyebrows, a depressed nasal tip, prominent ears, or persistent fingertip pads.
Genetic testing through sequencing of KMT2D and KDM6A is the most direct path to confirmation. For individuals who meet the clinical picture but test negative on standard sequencing, additional methods like methylation analysis (which looks at chemical patterns on DNA characteristic of the syndrome) can sometimes confirm the diagnosis.
Intellectual and Developmental Impact
Most people with Kabuki syndrome have mild to moderate intellectual disability. In one study of caregivers in the United States and Canada, IQ scores among affected individuals ranged from 40 to 91, with an average of 68 (compared to an average of 85 to 114 in the general population). The range is wide, and some individuals function near typical levels while others need substantial support.
Developmental milestones are consistently delayed. On average, children with Kabuki syndrome walk around age 2 (with some not walking until age 7), speak their first words around age 2 (range: 5 months to 5 years), and toilet train around age 5 (range: 2 to 14 years). Reading typically begins around age 7, with some children not reading until 13. Reciprocal play with others, a social milestone, averages around age 4 but can be delayed as late as 15.
Common cognitive challenges include difficulty with spatial reasoning, problem solving, and reproducing drawings. About half of affected individuals experience speech or language problems, and roughly a third have poor memory. Most need educational accommodations, and many require help with daily tasks into adulthood.
Heart, Kidney, and Other Organ Involvement
Kabuki syndrome can affect organs well beyond the brain and skeleton. Congenital heart defects are among the most clinically significant. Left-sided heart lesions, particularly coarctation of the aorta (a narrowing of the body’s main artery), account for nearly half of cardiac defects in this population. Holes between the heart’s chambers are also common. These often require surgical repair, and complications after heart surgery are more frequent in Kabuki patients than in the general pediatric population.
Kidney abnormalities show up in a substantial number of individuals, with structural differences like underdeveloped or malformed kidneys found in over 40% of those evaluated in one surgical cohort. Gastrointestinal issues including intestinal malrotation and anal abnormalities occur as well, though less frequently. Hearing loss, vision problems, and dental irregularities round out the list of systems that may be involved.
Immune System Vulnerability
Immune deficiency is an underrecognized but important aspect of Kabuki syndrome. Many affected individuals experience recurrent infections, particularly ear infections, due to low antibody levels (hypogammaglobulinemia). The underlying problem appears to be a defect in how infection-fighting B cells mature, leading to insufficient production of the antibodies that protect against bacteria and viruses. Some individuals also show poor responses to vaccines.
A registry study of 177 genetically confirmed Kabuki individuals found that autoimmune conditions are also more common than expected. Immune-related destruction of blood platelets occurred in about 7% and autoimmune anemia in 4%. Vitiligo, a condition where patches of skin lose pigment due to immune attack, was also frequent. These immune complications can be serious and may require ongoing treatment with antibody replacement therapy or immune-modulating medications.
Ongoing Care and Monitoring
Because Kabuki syndrome touches so many body systems, care involves a team of specialists rather than a single provider. At diagnosis, baseline evaluations typically include an echocardiogram to check for heart defects, a kidney ultrasound, an eye exam, and immune system bloodwork including antibody levels and immune cell counts, ideally completed by age 1.
Routine follow-up centers on tracking growth, developmental progress, hearing, and vision at every well-child visit. Thyroid function and blood counts are checked every two to three years. Depending on an individual’s specific complications, they may see cardiology, orthopedics, endocrinology, nephrology, and other specialists on an ongoing basis. Early intervention services for speech, occupational therapy, and physical therapy play a major role in helping children reach their developmental potential. A geneticist or genetic counselor is also valuable for family planning discussions and coordinating the bigger picture of care.